{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:43:27Z","timestamp":1777589007425,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2020-14\/200161"],"award-info":[{"award-number":["451-03-68\/2020-14\/200161"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.fct.2020.111639","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:27:57Z","timestamp":1595302077000},"page":"111639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-2565","authenticated-orcid":false,"given":"Dragana","family":"Javorac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazar","family":"Grahovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Mani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Stojilkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"An\u0111elkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorica","family":"Bulat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"\u0110uki\u0107 - \u0106osi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijana","family":"Curcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra Buha","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2020.111639_bib1","doi-asserted-by":"crossref","first-page":"104808","DOI":"10.1016\/j.phrs.2020.104808","article-title":"Plausibility of therapeutic effects of Rho kinase inhibitors against severe acute respiratory syndrome coronavirus 2 (COVID-19)","volume":"156","author":"Abedi","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.fct.2020.111639_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5937\/arhfarm1604161A","article-title":"Bezbednost primene lekova koji se koriste u terapiji HIV infekcije","volume":"66","author":"An\u0111elkovi\u0107","year":"2016","journal-title":"Arh. Farm. (Belgr.)"},{"key":"10.1016\/j.fct.2020.111639_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.fct.2020.111639_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13063-019-3846-x","article-title":"Treatment of Middle East respiratory syndrome with a combination of lopinavir\/ritonavir and interferon-\u03b21b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial","volume":"21","author":"Arabi","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.fct.2020.111639_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10633-018-9625-2","article-title":"Comparison between multifocal ERG and C-Scan SD-OCT (\u201cen face\u201d OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results","volume":"136","author":"Arndt","year":"2018","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.fct.2020.111639_bib6","first-page":"S31","article-title":"Drug prevention of influenza in pregnant women","volume":"11","author":"Belokrinitskaya","year":"2012","journal-title":"Quest. Gynecol. Obstet. Perinatol."},{"key":"10.1016\/j.fct.2020.111639_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e32830261f4","article-title":"Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications","volume":"22","author":"Beukel Van Den Bout-Van Den","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.fct.2020.111639_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","author":"Blaising","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2020.111639_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2005.03.003","article-title":"Predictive factors of lopinavir\/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals","volume":"26","author":"Bongiovanni","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.fct.2020.111639_bib10","first-page":"1","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fct.2020.111639_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2147\/TCRM.S3285","article-title":"Lopinavir\/ritonavir in the treatment of HIV-1 infection: a review","volume":"4","author":"Chandwani","year":"2008","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.fct.2020.111639_bib12","article-title":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.fct.2020.111639_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1345\/aph.1A363","article-title":"Kaletra (Lopinavir\/Ritonavir)","volume":"36","author":"Corbett","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.fct.2020.111639_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: a retrospective cohort study","author":"Deng","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.fct.2020.111639_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.fct.2020.111639_bib16","series-title":"Ritonavir, xPharm: the Comprehensive Pharmacology Reference","author":"Findlay","year":"2007"},{"key":"10.1016\/j.fct.2020.111639_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4269\/ajtmh.2007.77.929","article-title":"Azithromycin\/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized Guinea pig","volume":"77","author":"Fossa","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.fct.2020.111639_bib18","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"6","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.fct.2020.111639_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/0889222041524562","article-title":"Liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection","volume":"20","author":"Gonz\u00e1lez-Requena","year":"2004","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.fct.2020.111639_bib20","series-title":"Triglyceride Values after Six Months of Lopinavir\/ritonavir Therapy as an Indicator for Pancreatitis Risk","author":"Greffrath","year":"2016"},{"key":"10.1016\/j.fct.2020.111639_bib21","doi-asserted-by":"crossref","DOI":"10.4102\/sajhivmed.v19i1.766","article-title":"Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir\/ritonavir initiation","volume":"19","author":"Greffrath","year":"2018","journal-title":"South. Afr. J. HIV Med."},{"key":"10.1016\/j.fct.2020.111639_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe covid-19","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fct.2020.111639_bib23","series-title":"Arbidol\u2014a New Antiviral, Immunomodulator, Interferon Inducer","first-page":"63","article-title":"Efficacy and safety of arbidol in treating and prophylaxis of influenza: clinical trials","author":"Guskova","year":"1999"},{"key":"10.1016\/j.fct.2020.111639_bib24","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00204-019-02547-x","article-title":"Critical assessment and integration of separate lines of evidence for risk assessment of chemical mixtures","volume":"93","author":"Hernandez","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2020.111639_bib25","series-title":"Chloroquine and Hydroxychloroquine Toxicity, Archives of Ophthalmology","author":"Hickley","year":"2011"},{"key":"10.1016\/j.fct.2020.111639_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2020.111639_bib27","series-title":"Clinical Characteristics of Coronavirus Disease 2019 in Hangzhou, China\u00a0: the Combination of Lopinavir\/Ritonavir , Interferon , and Arbidol May Be a Well Choice for Antiviral Therapy in Common Cases 1\u201326","author":"Jaihua","year":"2020"},{"issue":"6","key":"10.1016\/j.fct.2020.111639_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","article-title":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms","volume":"69","author":"Jin","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.fct.2020.111639_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.fct.2020.111639_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111257","article-title":"A systems toxicology approach to compare the heavy metal mixtures (Pb, As, MeHg) impact in neurodegenerative diseases","volume":"139","author":"Karri","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2020.111639_bib31","article-title":"Setting safer exposure limits for toxic substance combinations","volume":"111346","author":"Kostoff","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2020.111639_bib32","first-page":"1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study [published online ahead of print, 2020 Apr 6]","author":"Lechien","year":"2020","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.fct.2020.111639_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fct.2020.111639_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.fct.2020.111639_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/OPX.0000000000001368","article-title":"Case report: retinal toxicity secondary to ritonavir","volume":"96","author":"Louie","year":"2019","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.fct.2020.111639_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.fct.2020.111639_bib37","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS Res. Palliat. Care"},{"key":"10.1016\/j.fct.2020.111639_bib38","first-page":"1","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","volume":"xx","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.fct.2020.111639_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/d41586-020-00444-3","article-title":"Slew of trials launch to test coronavirus treatments in China","volume":"578","author":"Maxmen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.fct.2020.111639_bib40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/INF.0b013e3181acd17e","article-title":"Twin preterm neonates with cardiac toxicity related to lopinavir\/ritonavir therapy","volume":"28","author":"McArthur","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.fct.2020.111639_bib41","series-title":"Potential Drug Candidates Underway Several Registered Clinical Trials for Battling COVID-19","author":"Mina","year":"2020"},{"key":"10.1016\/j.fct.2020.111639_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tmaid.2019.06.012","article-title":"A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"30","author":"Momattin","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.fct.2020.111639_bib43","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fct.2020.111639_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14740338.4.2.201","article-title":"Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics","volume":"4","author":"Nolan","year":"2005","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.fct.2020.111639_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2005.11.027","article-title":"Hepatotoxicity of antiretrovirals: incidence, mechanisms and management","volume":"44","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2020.111639_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tiv.2019.01.008","article-title":"Ascorbic acid prevents chloroquine-induced toxicity in inner glial cells","volume":"56","author":"Oliveira","year":"2019","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2020.111639_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICB.0000000000000350","article-title":"Ritonavir-associated toxicity mimicking retinitis pigmentosa in an hiv-infected patient on highly active antiretroviral therapy","volume":"11","author":"Papavasileiou","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.fct.2020.111639_bib48","article-title":"Editorial - novel Coronavirus 2019 (SARS-CoV2): a global emergency that needs new approaches?","author":"Perrella","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.fct.2020.111639_bib49","article-title":"Drug repurposing: progress, challenges and recommendations","author":"Pushpakom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fct.2020.111639_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.fct.2020.111639_bib51","doi-asserted-by":"crossref","first-page":"102066","DOI":"10.1016\/j.ajp.2020.102066","article-title":"COVID-19 and mental health: a review of the existing literature [published online ahead of print, 2020 Apr 10]","volume":"52","author":"Rajkumar","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.fct.2020.111639_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev. Panam. Salud P\u00fablic"},{"key":"10.1016\/j.fct.2020.111639_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-458","article-title":"Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults","volume":"13","author":"Sagara","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2020.111639_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2020.111639_bib55","series-title":"A Joint Research Team of the Shanghai Institute of Materia Medica and Shanghai Tech University Discover a Group of Old and Traditional Chinese Medicines that May Be Efficacious in Treating the Novel Form of Pneumonia","year":"2020"},{"key":"10.1016\/j.fct.2020.111639_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.fct.2020.111639_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.fct.2020.111639_bib58","series-title":"Handbook of COVID-19 Prevention and Treatment, Handbook of Covid-19, Prevention and Treatment. The First Affiliated Hospital","author":"Tingbo","year":"2020"},{"key":"10.1016\/j.fct.2020.111639_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2020.111639_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fct.2018.12.043","article-title":"Hormetic Neurobehavioral effects of low dose toxic chemical mixtures in real-life risk simulation (RLRS) in rats","volume":"125","author":"Tsatsakis","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2020.111639_bib61","article-title":"Retinal toxicity with ritonavir","author":"Tu","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.fct.2020.111639_bib62","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/2271257a0","article-title":"Accumulation of chorio-retinotoxic drugs in the foetal eye","volume":"227","author":"Ullberg","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.fct.2020.111639_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","author":"Van den Broek","year":"2020","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.fct.2020.111639_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.fct.2020.111639_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/01480540903311050","article-title":"A 4-week oral toxicity study of an antiviral drug combination consisting of arbidol and acetaminophen in rats","volume":"33","author":"Wang","year":"2010","journal-title":"Drug Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.fct.2020.111639_bib66","first-page":"289","article-title":"Efficacy and safety of arbidol in treatment of naturally acquired influenza","volume":"26","author":"Wang","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.fct.2020.111639_bib67","series-title":"WHO R&D Blueprint \u2013 Ad-Hoc Expert Consultation on Clinical Trials for Ebola Therapeutics","author":"WHO","year":"2018"},{"key":"10.1016\/j.fct.2020.111639_bib68","series-title":"Coronavirus Disease 2019 (COVID-19) Situation Report \u2013 153","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.fct.2020.111639_bib69","series-title":"Coronavirus Disease 2019 (COVID-19) Situation Report \u2013 51","author":"World Health organzation","year":"2020"},{"key":"10.1016\/j.fct.2020.111639_bib70","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41433-018-0136-x","article-title":"The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary consensus-statement","volume":"32","author":"Yusuf","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.fct.2020.111639_bib71","article-title":"Clinical trial analysis of 2019-nCoV therapy registered in China","author":"Zhang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.fct.2020.111639_bib72","article-title":"Long-term toxicity of arbidol in rats","volume":"17","author":"Zhou","year":"2006","journal-title":"Chin. J. New Drugs"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691520305299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691520305299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:01:26Z","timestamp":1759528886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691520305299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":72,"alternative-id":["S0278691520305299"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2020.111639","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2020.111639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111639"}}